| Molecular fields in quantitative structure–permeation relationships: the VolSurf approach G Cruciani, P Crivori, PA Carrupt, B Testa Journal of Molecular Structure: THEOCHEM 503 (1-2), 17-30, 2000 | 725 | 2000 |
| Predicting blood− brain barrier permeation from three-dimensional molecular structure P Crivori, G Cruciani, PA Carrupt, B Testa Journal of medicinal chemistry 43 (11), 2204-2216, 2000 | 587 | 2000 |
| Drug–protein binding: a critical review of analytical tools K Vuignier, J Schappler, JL Veuthey, PA Carrupt, S Martel Analytical and bioanalytical chemistry 398, 53-66, 2010 | 435 | 2010 |
| Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase C Brühlmann, F Ooms, PA Carrupt, B Testa, M Catto, F Leonetti, ... Journal of Medicinal Chemistry 44 (19), 3195-3198, 2001 | 403 | 2001 |
| HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs? C Simões-Pires, V Zwick, A Nurisso, E Schenker, PA Carrupt, M Cuendet Molecular neurodegeneration 8, 1-16, 2013 | 355 | 2013 |
| Molecular lipophilicity potential, a tool in 3D QSAR: method and applications P Gaillard, PA Carrupt, B Testa, A Boudon Journal of computer-aided molecular design 8, 83-96, 1994 | 341 | 1994 |
| Stereoselective Block of hERG Channel by (S)‐Methadone and QT Interval Prolongation in CYP2B6 Slow Metabolizers CB Eap, S Crettol, JS Rougier, J Schläpfer, L Sintra Grilo, JJ Déglon, ... Clinical Pharmacology & Therapeutics 81 (5), 719-728, 2007 | 330 | 2007 |
| Inhibition of monoamine oxidases by functionalized coumarin derivatives: biological activities, QSARs, and 3D-QSARs C Gnerre, M Catto, F Leonetti, P Weber, PA Carrupt, C Altomare, A Carotti, ... Journal of medicinal chemistry 43 (25), 4747-4758, 2000 | 319 | 2000 |
| The influence of lipophilicity on the pharmacokinetic behavior of drugs: Concepts and examples B Testa, P Crivori, M Reist, PA Carrupt Perspectives in Drug Discovery and Design 19, 179-211, 2000 | 304 | 2000 |
| Structure–property relationships of trimetazidine derivatives and model compounds as potential antioxidants J Ancerewicz, E Migliavacca, PA Carrupt, B Testa, F Brée, R Zini, ... Free Radical Biology and Medicine 25 (1), 113-120, 1998 | 281 | 1998 |
| Morphine 6-glucuronide and morphine 3-glucuronide as molecular chameleons with unexpected lipophilicity PA Carrupt, B Testa, A Bechalany, N El Tayar, P Descas, D Perrissoud Journal of medicinal chemistry 34 (4), 1272-1275, 1991 | 261 | 1991 |
| Monoamine oxidase inhibition by Rhodiola rosea L. roots D Van Diermen, A Marston, J Bravo, M Reist, PA Carrupt, K Hostettmann Journal of ethnopharmacology 122 (2), 397-401, 2009 | 260 | 2009 |
| Antimitotic and antiproliferative activities of chalcones: forward structure–activity relationship A Boumendjel, J Boccard, PA Carrupt, E Nicolle, M Blanc, A Geze, ... Journal of medicinal chemistry 51 (7), 2307-2310, 2008 | 248 | 2008 |
| Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability G Ottaviani, S Martel, PA Carrupt Journal of medicinal chemistry 49 (13), 3948-3954, 2006 | 240 | 2006 |
| Percutaneous penetration of drugs: a quantitative structure‐permeability relationship study NE Tayar, RS Tsai, B Testa, PA Carrupt, C Hansch, A Leo Journal of pharmaceutical sciences 80 (8), 744-749, 1991 | 218 | 1991 |
| Partitioning of solutes in different solvent systems: the contribution of hydrogen-bonding capacity and polarity N El Tayar, RS Tsai, B Testa, PA Carrupt, A Leo Journal of pharmaceutical sciences 80 (6), 590-598, 1991 | 218 | 1991 |
| Lipophilicity in molecular modeling B Testa, PA Carrupt, P Gaillard, F Billois, P Weber Pharmaceutical research 13, 335-343, 1996 | 204 | 1996 |
| Liposome/water lipophilicity: methods, information content, and pharmaceutical applications GP van Balen, CM Martinet, G Caron, G Bouchard, M Reist, PA Carrupt, ... Medicinal research reviews 24 (3), 299-324, 2004 | 188 | 2004 |
| Chiral inversion and hydrolysis of thalidomide: mechanisms and catalysis by bases and serum albumin, and chiral stability of teratogenic metabolites M Reist, PA Carrupt, E Francotte, B Testa Chemical research in toxicology 11 (12), 1521-1528, 1998 | 185 | 1998 |
| Quantitative structure-permeation relationships (QSPeRs) to predict skin permeation: a critical evaluation S Geinoz, RH Guy, B Testa, PA Carrupt Pharmaceutical Research 21, 83-92, 2004 | 180 | 2004 |
Veuthey Jean-LucProfesseur en pharmacie, Université de Genève在 unige.ch 的电子邮件经过验证
